Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

Synthetic binders developer Aptamer Group has signed a licensing agreement with Alphazyme for the use of an Optimer binder in ...

DNA origami cages constrain individual proteins toward preferred orientations on electrodes, dramatically improving electrical measurement precision and enabling detection of subtle structural changes ...

Precise tumor diagnosis and treatment require the support of abundant molecular information. However, conventional molecular ...

A research group at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has identified a candidate ...

A research group at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has identified a ...

Aptamer Group Plc ( (GB:APTA) ) has provided an update.

A research group at the Italian Institute of Technology (Istituto Italiano di Tecnologia - IIT) has identified a candidate molecule that could improve current therapies against pancreatic cancer. The ...

Saga PLC - Kent, England-based provider of products and services for people over 50 - Announces that its 20-year motor and home insurance partnership with Ageas UK, wholly-owned subsidiary of Ageas SA ...

York-based biotech firm Aptamer Group has announced a licensing agreement with synthetic biology and genomics company Twist ...

Senescent “zombie” cells are linked to aging and multiple diseases, but spotting them in living tissue has been notoriously ...